The global sales of the Drug Testing Market in 2022 were held at US$ 6.3 Bn. With a CAGR of 5.3% during 2023 - 2033, the market is projected to reach a valuation of US$ 15.7 Bn by 2033.
Consumables are expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 6.3% during 2023 – 2033.
As per the drug testing market research by Transparency Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the value of the market increased at around 4.6% CAGR.
To detect illicit and some prescription medications in biological samples drug testing is put to use. It is also used to screen blood and urine samples. Drug testing is also required for assessing the usage of drugs and is an essential component of therapy and evaluation. Drug testing is employed in hospitals and schools and in workplaces. It is also used for post-accident drug testing as well as for collegiate and professional athletes’ drug testing.
Furthermore, at the collegiate level and for professional athletes, sports drug testing is necessary to screen for illegal, recreational, or performance-enhancing medications. Heroin, cannabis, cocaine, ecstasy, and amphetamine are some of the most often used illegal narcotics.
Marijuana, Cocaine, oxycodone, ecstasy, opiates, methamphetamine, and other substances are detected by drug testing methods. Drug testing systems are utilized in treatment clinics, correctional facilities, and industrial settings. Substance testing is one of the fast-changing technologies used to detect the usage of a particular drug.
The progress of technology in devices, which increases sensitivity, reduces time, and detects newly invented designer drugs, is a major reason driving the expansion of drug testing systems.
Enhanced consumption of alcohol and opioids deteriorates health. Drug testing devices are in more demand because of the initiatives of the government to assist drug abusers. Because of more drug testing and its abuse, the market is likely to boost.
In recent times, advanced solutions for drug testing are likely to enter the market which is easy to use and precise. The use of illegal drugs is increasing rapidly in many developed and developing countries, which has a negative impact on individuals' physical and mental health. The market for drug testing systems is expected to be driven by rising drug and alcohol consumption during the forecast period.
Drug testing is in more demand because of Increasing drug and alcohol abuse, as well as the rising geriatric population which is putting a load on the drug testing market. Increasing government financial support and drug testing initiatives, and growing knowledge regarding drug testing in developed countries have created factors that would enhance the market growth. Additionally, as the consumption of drugs keeps on rising, it will continue to keep the market upside.
However, there are some restrictions in certain nations regarding drug testing since it is regarded as a breach of privacy rights. Also, accuracy concerns with breathalyzers and the ban on the consumption of substances are a few additional restrictions.
Due to an increase in the number of drug and alcohol addiction cases and the passage of rigorous legislation in the region, North America leads the global market for drug testing in the world owing to more cases of drug and alcohol addiction and the employment of stringent legislation region.
Other factors driving the region's enhanced performance include the existence of notable players executing substantial growth strategies and strict laws for workplace testing. Furthermore, attractive reimbursement conditions and the region's high adoption of technologically sophisticated solutions have fuelled drug testing market expansion.
During the projected period, the market in Asia Pacific is predicted to increase considerably. Countries such as China and India, which create a need for drug misuse testing, are important drivers of its expansion. These countries see the necessity for drug testing programs as a result of drug-related crime, road accidents, and substance addiction difficulties.
The United States is expected to have the highest market share of US$ 5.5 Bn by the end of 2033. The United States experienced a harsher drug addiction epidemic during the COVID-19 pandemic. During the pandemic, more than one in every ten individuals began or increased their use of alcohol or drugs. As a result, the number of people dying as a result of a drug overdose has increased. This has significantly raised the demand for the drug testing business in the United States.
Consumables commanded the largest revenue in this regard and grew at a CAGR of nearly 5% during 2015-21 and are now forecasted to grow at a CAGR of 6.3% throughout the forecasted period.
The increased availability of modern consumables that give enhanced solutions for making testing simple, precise, and quick has propelled drug screening market expansion.
The service category had the second-largest share in revenue in 2020. The segment has expanded through a number of strategic activities such as acquisitions by numerous organizations along with association and alliance formation to serve public safety and government agencies.
Drug Testing Laboratories commanded the largest revenue in this regard and grew at a CAGR of nearly 6% during 2018-22 and are forecasted to grow at a CAGR of 5.8% throughout the forecasted period.
This large proportion can be attributable to their widespread acceptance as a consequence of their precise outcomes. Rapid tests cannot detect the presence of any illicit substance, whereas drug testing facilities can. As a result, laboratories produce more sensitive and specific testing findings than fast tests.
Drug traffickers have swiftly rebounded from early setbacks caused by lockdown limitations, owing to an increase in the use of technology. These reasons have been raising the demand for drug testing products.
Travel restrictions and lockdowns, as well as restrictions on corporate operations, public gatherings, and shelter-in-place orders, have hampered the market expansion. Several governments throughout the world have announced countrywide lockdowns and temporary closures of industries, manufacturing, production, and commercial development. Trade obstacles have exacerbated the demand-supply imbalance. Customers in the drug testing business have seen interruptions in the global supply chain, diminished demand, or the cessation of operations.
To grab higher market shares, key corporations are pursuing various growth methods such as new product development, mergers and acquisitions, and regional expansion.
Some of the key players operating in the drug testing industry include Quest Diagnostics Incorporated, Abbott Laboratories, Quidel Corporation, F. Hoffmann-La Roche, Thermo Fisher Scientific, Inc., Gene By Gene, Ltd., 23andMe, Inc., Color Genomics, Inc., Myriad Genetics, Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories, Inc., bioMerieux SA, Quest Diagnostics, Aeromedevac, Air Methods, ALPHASTAR, and Babcock Scandinavian AirAmbulance.
Some of the recent developments in key drug testing companies are as follows:
Similarly, recent developments related to the companies in the Drug Testing business have been tracked by the team at Transparency Market Research, which is available in the full report.
By Component
By Sample Type
By Drug Type
By End Use
By Region
|
Attribute |
Details |
|
Global Drug Testing Market (2023) |
US$ 9.4 Bn |
|
Global Drug Testing Industry (2033) |
US$ 15.7 Bn |
|
Global Drug Screening Market CAGR (2023 – 2033) |
5.3% |
|
U.S. Drug Testing Market CAGR (2023 – 2033) |
6% |
|
Key Companies Profiled |
|
The market is worth more than US$ 6.3 Bn at present.
The market value is projected to increase at a CAGR of around 5.3% during 2023 – 2033.
The market value increased at a CAGR of around 4.6% during 2018 – 2022.
Growing drug and alcohol addiction, a growing elderly population, high use of alcohol and prescription and illegal drugs, and a growing worldwide population are some of the primary reasons driving the global drug testing market's rise.
The market of drug testing in China is projected to expand at a CAGR of around 6.3% during 2023 – 2033.
While the market in South Korea is expected to grow at nearly 4.9%, the market in Japan is projected to register a CAGR of nearly 4.6% during 2023 - 2033.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Drug Testing Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Component
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Component , 2018-2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Component , 2023-2033
5.3.1. Consumables
5.3.2. Instruments
5.3.3. Rapid Testing Devices
5.3.4. Services
5.4. Y-o-Y Growth Trend Analysis By Component , 2018-2022
5.5. Absolute $ Opportunity Analysis By Component , 2023-2033
6. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Sample Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Sample Type, 2018-2022
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Sample Type, 2023-2033
6.3.1. Urine Samples
6.3.2. Oral Fluid Samples
6.3.3. Hair Samples
6.3.4. Other Samples
6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2018-2022
6.5. Absolute $ Opportunity Analysis By Sample Type, 2023-2033
7. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type , 2018-2022
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type , 2023-2033
7.3.1. Alcohol
7.3.2. Cannabis/Marijuana
7.3.3. Cocaine
7.3.4. Opioids
7.3.5. Amphetamine & Methamphetamine
7.3.6. LSD
7.3.7. Other Drug Types
7.4. Y-o-Y Growth Trend Analysis By Drug Type , 2018-2022
7.5. Absolute $ Opportunity Analysis By Drug Type , 2023-2033
8. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By End-use
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End-use, 2018-2022
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-use, 2023-2033
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Other End-uses
8.4. Y-o-Y Growth Trend Analysis By End-use, 2018-2022
8.5. Absolute $ Opportunity Analysis By End-use, 2023-2033
9. Global Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. Middle East and Africa
9.4. Market Attractiveness Analysis By Region
10. North America Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Component
10.2.3. By Sample Type
10.2.4. By Drug Type
10.2.5. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Component
10.3.3. By Sample Type
10.3.4. By Drug Type
10.3.5. By End-use
10.4. Key Takeaways
11. Latin America Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Component
11.2.3. By Sample Type
11.2.4. By Drug Type
11.2.5. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Component
11.3.3. By Sample Type
11.3.4. By Drug Type
11.3.5. By End-use
11.4. Key Takeaways
12. Europe Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. U.K.
12.2.1.5. Russia
12.2.1.6. BENELUX
12.2.1.7. Rest of Europe
12.2.2. By Component
12.2.3. By Sample Type
12.2.4. By Drug Type
12.2.5. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Component
12.3.3. By Sample Type
12.3.4. By Drug Type
12.3.5. By End-use
12.4. Key Takeaways
13. Asia Pacific Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. Rest of Asia Pacific
13.2.2. By Component
13.2.3. By Sample Type
13.2.4. By Drug Type
13.2.5. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Component
13.3.3. By Sample Type
13.3.4. By Drug Type
13.3.5. By End-use
13.4. Key Takeaways
14. Middle East and Africa Drug Testing Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Turkey
14.2.1.4. Rest of Middle East and Africa
14.2.2. By Component
14.2.3. By Sample Type
14.2.4. By Drug Type
14.2.5. By End-use
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Component
14.3.3. By Sample Type
14.3.4. By Drug Type
14.3.5. By End-use
14.4. Key Takeaways
15. Key Countries Drug Testing Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2022
15.1.2.1. By Component
15.1.2.2. By Sample Type
15.1.2.3. By Drug Type
15.1.2.4. By End-use
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2022
15.2.2.1. By Component
15.2.2.2. By Sample Type
15.2.2.3. By Drug Type
15.2.2.4. By End-use
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2022
15.3.2.1. By Component
15.3.2.2. By Sample Type
15.3.2.3. By Drug Type
15.3.2.4. By End-use
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2022
15.4.2.1. By Component
15.4.2.2. By Sample Type
15.4.2.3. By Drug Type
15.4.2.4. By End-use
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2022
15.5.2.1. By Component
15.5.2.2. By Sample Type
15.5.2.3. By Drug Type
15.5.2.4. By End-use
15.6. Italy
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2022
15.6.2.1. By Component
15.6.2.2. By Sample Type
15.6.2.3. By Drug Type
15.6.2.4. By End-use
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2022
15.7.2.1. By Component
15.7.2.2. By Sample Type
15.7.2.3. By Drug Type
15.7.2.4. By End-use
15.8. U.K.
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2022
15.8.2.1. By Component
15.8.2.2. By Sample Type
15.8.2.3. By Drug Type
15.8.2.4. By End-use
15.9. Russia
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2022
15.9.2.1. By Component
15.9.2.2. By Sample Type
15.9.2.3. By Drug Type
15.9.2.4. By End-use
15.10. BENELUX
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2022
15.10.2.1. By Component
15.10.2.2. By Sample Type
15.10.2.3. By Drug Type
15.10.2.4. By End-use
15.11. China
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2022
15.11.2.1. By Component
15.11.2.2. By Sample Type
15.11.2.3. By Drug Type
15.11.2.4. By End-use
15.12. Japan
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2022
15.12.2.1. By Component
15.12.2.2. By Sample Type
15.12.2.3. By Drug Type
15.12.2.4. By End-use
15.13. South Korea
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2022
15.13.2.1. By Component
15.13.2.2. By Sample Type
15.13.2.3. By Drug Type
15.13.2.4. By End-use
15.14. GCC Countries
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2022
15.14.2.1. By Component
15.14.2.2. By Sample Type
15.14.2.3. By Drug Type
15.14.2.4. By End-use
15.15. South Africa
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2022
15.15.2.1. By Component
15.15.2.2. By Sample Type
15.15.2.3. By Drug Type
15.15.2.4. By End-use
15.16. Turkey
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2022
15.16.2.1. By Component
15.16.2.2. By Sample Type
15.16.2.3. By Drug Type
15.16.2.4. By End-use
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Component
16.3.3. By Sample Type
16.3.4. By Drug Type
16.3.5. By End-use
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Quest Diagnostics Incorporated
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.2. Abbott Laboratories
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.3. Quidel Corporation
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.4. F. Hoffmann-La Roche
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.5. Thermo Fisher Scientific, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.6. Siemens Healthineers
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.7. Bio-Rad Laboratories, Inc.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.8. Agilent Technologies, Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.9. LabCorp
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.10. Drägerwerk AG & CO. KGaA
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.11. Clinical Reference Laboratory (CRL), Inc.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.12. Cordant Health Solutions
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.13. Legacy Medical Services, LLC
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.14. Omega Laboratories, Inc.
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
List of Tables
Table 1: Global Drug Testing Market Value (US$ Mn) Forecast by Region, 2018-2033
Table 2: Global Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033
Table 3: Global Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033
Table 4: Global Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033
Table 5: Global Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 6: North America Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 7: North America Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033
Table 8: North America Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033
Table 9: North America Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033
Table 10: North America Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 11: Latin America Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 12: Latin America Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033
Table 13: Latin America Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033
Table 14: Latin America Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033
Table 15: Latin America Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 16: Europe Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 17: Europe Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033
Table 18: Europe Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033
Table 19: Europe Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033
Table 20: Europe Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 21: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 22: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033
Table 23: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033
Table 24: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033
Table 25: Asia Pacific Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033
Table 26: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 27: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Component , 2018-2033
Table 28: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Sample Type, 2018-2033
Table 29: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by Drug Type , 2018-2033
Table 30: Middle East and Africa Drug Testing Market Value (US$ Mn) Forecast by End-use, 2018-2033
List of Figures
Figure 1: Global Drug Testing Market Value (US$ Mn) by Component , 2023-2033
Figure 2: Global Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033
Figure 3: Global Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033
Figure 4: Global Drug Testing Market Value (US$ Mn) by End-use, 2023-2033
Figure 5: Global Drug Testing Market Value (US$ Mn) by Region, 2023-2033
Figure 6: Global Drug Testing Market Value (US$ Mn) Analysis by Region, 2018-2033
Figure 7: Global Drug Testing Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 8: Global Drug Testing Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 9: Global Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033
Figure 10: Global Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033
Figure 11: Global Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033
Figure 12: Global Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033
Figure 13: Global Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033
Figure 14: Global Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033
Figure 15: Global Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033
Figure 16: Global Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033
Figure 17: Global Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033
Figure 18: Global Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 19: Global Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 20: Global Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 21: Global Drug Testing Market Attractiveness by Component , 2023-2033
Figure 22: Global Drug Testing Market Attractiveness by Sample Type, 2023-2033
Figure 23: Global Drug Testing Market Attractiveness by Drug Type , 2023-2033
Figure 24: Global Drug Testing Market Attractiveness by End-use, 2023-2033
Figure 25: Global Drug Testing Market Attractiveness by Region, 2023-2033
Figure 26: North America Drug Testing Market Value (US$ Mn) by Component , 2023-2033
Figure 27: North America Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033
Figure 28: North America Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033
Figure 29: North America Drug Testing Market Value (US$ Mn) by End-use, 2023-2033
Figure 30: North America Drug Testing Market Value (US$ Mn) by Country, 2023-2033
Figure 31: North America Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 32: North America Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 33: North America Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 34: North America Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033
Figure 35: North America Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033
Figure 36: North America Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033
Figure 37: North America Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033
Figure 38: North America Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033
Figure 39: North America Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033
Figure 40: North America Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033
Figure 41: North America Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033
Figure 42: North America Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033
Figure 43: North America Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 44: North America Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 45: North America Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 46: North America Drug Testing Market Attractiveness by Component , 2023-2033
Figure 47: North America Drug Testing Market Attractiveness by Sample Type, 2023-2033
Figure 48: North America Drug Testing Market Attractiveness by Drug Type , 2023-2033
Figure 49: North America Drug Testing Market Attractiveness by End-use, 2023-2033
Figure 50: North America Drug Testing Market Attractiveness by Country, 2023-2033
Figure 51: Latin America Drug Testing Market Value (US$ Mn) by Component , 2023-2033
Figure 52: Latin America Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033
Figure 53: Latin America Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033
Figure 54: Latin America Drug Testing Market Value (US$ Mn) by End-use, 2023-2033
Figure 55: Latin America Drug Testing Market Value (US$ Mn) by Country, 2023-2033
Figure 56: Latin America Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 57: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 58: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 59: Latin America Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033
Figure 60: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033
Figure 61: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033
Figure 62: Latin America Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033
Figure 63: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033
Figure 64: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033
Figure 65: Latin America Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033
Figure 66: Latin America Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033
Figure 67: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033
Figure 68: Latin America Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 69: Latin America Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 70: Latin America Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 71: Latin America Drug Testing Market Attractiveness by Component , 2023-2033
Figure 72: Latin America Drug Testing Market Attractiveness by Sample Type, 2023-2033
Figure 73: Latin America Drug Testing Market Attractiveness by Drug Type , 2023-2033
Figure 74: Latin America Drug Testing Market Attractiveness by End-use, 2023-2033
Figure 75: Latin America Drug Testing Market Attractiveness by Country, 2023-2033
Figure 76: Europe Drug Testing Market Value (US$ Mn) by Component , 2023-2033
Figure 77: Europe Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033
Figure 78: Europe Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033
Figure 79: Europe Drug Testing Market Value (US$ Mn) by End-use, 2023-2033
Figure 80: Europe Drug Testing Market Value (US$ Mn) by Country, 2023-2033
Figure 81: Europe Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 82: Europe Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 83: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 84: Europe Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033
Figure 85: Europe Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033
Figure 86: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033
Figure 87: Europe Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033
Figure 88: Europe Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033
Figure 89: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033
Figure 90: Europe Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033
Figure 91: Europe Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033
Figure 92: Europe Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033
Figure 93: Europe Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 94: Europe Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 95: Europe Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 96: Europe Drug Testing Market Attractiveness by Component , 2023-2033
Figure 97: Europe Drug Testing Market Attractiveness by Sample Type, 2023-2033
Figure 98: Europe Drug Testing Market Attractiveness by Drug Type , 2023-2033
Figure 99: Europe Drug Testing Market Attractiveness by End-use, 2023-2033
Figure 100: Europe Drug Testing Market Attractiveness by Country, 2023-2033
Figure 101: Asia Pacific Drug Testing Market Value (US$ Mn) by Component , 2023-2033
Figure 102: Asia Pacific Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033
Figure 103: Asia Pacific Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033
Figure 104: Asia Pacific Drug Testing Market Value (US$ Mn) by End-use, 2023-2033
Figure 105: Asia Pacific Drug Testing Market Value (US$ Mn) by Country, 2023-2033
Figure 106: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 107: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 108: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 109: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033
Figure 110: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033
Figure 111: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033
Figure 112: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033
Figure 113: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033
Figure 114: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033
Figure 115: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033
Figure 116: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033
Figure 117: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033
Figure 118: Asia Pacific Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 119: Asia Pacific Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 120: Asia Pacific Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 121: Asia Pacific Drug Testing Market Attractiveness by Component , 2023-2033
Figure 122: Asia Pacific Drug Testing Market Attractiveness by Sample Type, 2023-2033
Figure 123: Asia Pacific Drug Testing Market Attractiveness by Drug Type , 2023-2033
Figure 124: Asia Pacific Drug Testing Market Attractiveness by End-use, 2023-2033
Figure 125: Asia Pacific Drug Testing Market Attractiveness by Country, 2023-2033
Figure 126: Middle East and Africa Drug Testing Market Value (US$ Mn) by Component , 2023-2033
Figure 127: Middle East and Africa Drug Testing Market Value (US$ Mn) by Sample Type, 2023-2033
Figure 128: Middle East and Africa Drug Testing Market Value (US$ Mn) by Drug Type , 2023-2033
Figure 129: Middle East and Africa Drug Testing Market Value (US$ Mn) by End-use, 2023-2033
Figure 130: Middle East and Africa Drug Testing Market Value (US$ Mn) by Country, 2023-2033
Figure 131: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 132: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 133: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 134: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Component , 2018-2033
Figure 135: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Component , 2023-2033
Figure 136: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Component , 2023-2033
Figure 137: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Sample Type, 2018-2033
Figure 138: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Sample Type, 2023-2033
Figure 139: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Sample Type, 2023-2033
Figure 140: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by Drug Type , 2018-2033
Figure 141: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by Drug Type , 2023-2033
Figure 142: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by Drug Type , 2023-2033
Figure 143: Middle East and Africa Drug Testing Market Value (US$ Mn) Analysis by End-use, 2018-2033
Figure 144: Middle East and Africa Drug Testing Market Value Share (%) and BPS Analysis by End-use, 2023-2033
Figure 145: Middle East and Africa Drug Testing Market Y-o-Y Growth (%) Projections by End-use, 2023-2033
Figure 146: Middle East and Africa Drug Testing Market Attractiveness by Component , 2023-2033
Figure 147: Middle East and Africa Drug Testing Market Attractiveness by Sample Type, 2023-2033
Figure 148: Middle East and Africa Drug Testing Market Attractiveness by Drug Type , 2023-2033
Figure 149: Middle East and Africa Drug Testing Market Attractiveness by End-use, 2023-2033
Figure 150: Middle East and Africa Drug Testing Market Attractiveness by Country, 2023-2033
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Drug Testing Market
